| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Simcere Zaiming, Inc. | 10%+ Owner | $152,386 | 20 Jun 2025 | ||
| Kevin G. Shaw | Sr VP, General Counsel | 30 Jan 2026 | |||
| Han Myint | Chief Medical Officer | 29 Mar 2024 | |||
| Udayan Guha | Chief Medical Officer | 30 Jan 2026 | |||
| KABAKOFF DAVID S | Director | 20 Jun 2025 | |||
| Ellen Feigal | Director | 20 Jun 2025 | |||
| Michael Richman | President & CEO, Director | 30 Jan 2026 | |||
| Stella Xu | Director | 24 Jun 2021 | |||
| Chau Q. Khuong | Director | 22 Jun 2023 | |||
| Stephen W. Webster | Director | 20 Jun 2025 | |||
| Linda Liu | SVP, Research | 31 Jan 2022 | |||
| Sourav Kundu | Sr VP, Dev. & Mfg. | 30 Jan 2026 | |||
| Anne Elizabeth Borgman | Director | 20 Jun 2025 | |||
| Elaine V Jones | Director | 20 Jun 2025 | |||
| Sol Langermann | Chief Scientific Officer | 31 Jan 2025 | |||
| Steven P. Cobourn | Chief Financial Officer | 30 Jan 2026 | |||
| Timothy Mayer | Chief Operating Officer | 30 Jan 2026 | |||
| Garry A. Nicholson | Director | 22 Jun 2023 | |||
| John G. Houston | Director | 20 Jun 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Kevin G. Shaw | NXTC | Employee Stock Option (Right to Buy) | Award | 8,270 | 8,270 | 30 Jan 2026 | Direct | |||
| Sourav Kundu | NXTC | Employee Stock Option (Right to Buy) | Award | 8,270 | 8,270 | 30 Jan 2026 | Direct | |||
| Timothy Mayer | NXTC | Employee Stock Option (Right to Buy) | Award | 14,670 | 14,670 | 30 Jan 2026 | Direct | |||
| Udayan Guha | NXTC | Employee Stock Option (Right to Buy) | Award | 14,670 | 14,670 | 30 Jan 2026 | Direct | |||
| Steven P. Cobourn | NXTC | Employee Stock Option (Right to Buy) | Award | 14,670 | 14,670 | 30 Jan 2026 | Direct | |||
| Michael Richman | NXTC | Employee Stock Option (Right to Buy) | Award | 38,190 | 38,190 | 30 Jan 2026 | Direct | |||
| John G. Houston | NXTC | Stock Option (Right to Buy) | Award | 18,700 | 18,700 | 20 Jun 2025 | Direct | |||
| Elaine V Jones | NXTC | Stock Option (Right to Buy) | Award | 18,700 | 18,700 | 20 Jun 2025 | Direct | |||
| Kabakoff David S | NXTC | Stock Option (Right to Buy) | Award | 28,050 | 28,050 | 20 Jun 2025 | Direct | |||
| Anne Elizabeth Borgman | NXTC | Stock Option (Right to Buy) | Award | 18,700 | 18,700 | 20 Jun 2025 | Direct | |||
| Stephen W. Webster | NXTC | Stock Option (Right to Buy) | Award | 18,700 | 18,700 | 20 Jun 2025 | Direct | |||
| Ellen Feigal | NXTC | Stock Option (Right to Buy) | Award | 18,700 | 18,700 | 20 Jun 2025 | Direct |